FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Chirality / Development and validation of a chiral LC-MS method for the ...
Chirality2020; 32(3); 314-323; doi: 10.1002/chir.23166

Development and validation of a chiral LC-MS method for the enantiomeric resolution of (+) and (-)-medetomidine in equine plasma by using polysaccharide-based chiral stationary phases.

Abstract: The detection and separation of medetomidine enantiomers from the complex biological matrices poses a great analytical challenge, especially in the field of forensic toxicology and pharmacology. Couple of researchers reported resolution of medetomidine using protein-based chiral columns, but the reported method is quiet challenging and tedious to be employed for routine analysis. This research paper reported a method that enables the enantio-separation of medetomidine by using polysaccharide cellulose chiral column. The use of chiralcel OJ-3R column was found to have the highest potential for successful chiral resolution. Ammonium hydrogen carbonate was the ideal buffer salt for chiral liquid chromatography (LC) with electrospray ionization (ESI)+ mass spectrometry (MS) detection for the successful separation and detection of racemic compound. The method was linear over the range of 0 to 20 ng/mL in equine plasma and the inter-day precisions of levomedetomidine, dexmedetomidine were 1.36% and 1.89%, respectively. The accuracy of levomedetomidine was in the range of 99.25% to 101.57% and that for dexmedetomidine was 99.17% to 100.99%. The limits of quantification for both isomers were 0.2 ng/mL. Recovery and matrix effect on the analytes were also evaluated. Under the optimized conditions, the validated method can be adapted for the identification and resolution of the medetomidine enantiomers in different matrices used for drug testing and analysis.
© 2020 Wiley Periodicals, Inc.
Get Full Text
Publication Date: 2020-01-10 PubMed ID: 31925851DOI: 10.1002/chir.23166Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Validation Study

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article focuses on devising a simpler and more efficient method for the detection and separation of medetomidine enantiomers in equine plasma using a polysaccharide cellulose chiral column, specifically the chiralcel OJ-3R. The new method proves to be accurate and efficient, offering potential for routine analysis in forensic toxicology and pharmacology.

Background

  • The primary challenges highlighted in the paper are the detection and separation of medetomidine enantiomers from complex biological matrices. These challenges are particularly relevant in forensic toxicology and pharmacology.
  • Previous research had attempted to resolve medetomidine using protein-based chiral columns, but these methods were found to be difficult and cumbersome for regular use.

Methodology

  • The researchers introduced a new method for separating medetomidine enantiomers using a polysaccharide cellulose chiral column.
  • The chiralcel OJ-3R column demonstrated the most potential for successful chiral resolution out of the various columns tested.
  • Ammonium hydrogen carbonate was found to be the optimal buffer salt for chiral liquid chromatography (LC), with electrospray ionization (ESI)+ mass spectrometry (MS) detection enabling the successful separation and detection of the racemic compound.

Results and Analysis

  • The method proved linear over a range of 0 to 20 ng/mL in equine plasma with the inter-day precisions of levomedetomidine and dexmedetomidine at 1.36% and 1.89%, respectively.
  • Accuracy rates were high: levomedetomidine ranged from 99.25% to 101.57%, while dexmedetomidine ranged from 99.17% to 100.99%.
  • The limits of quantification for both isomers were 0.2 ng/mL, illustrating high precision.
  • Recovery and the matrix effect on the analytes were also evaluated and factored into the overall assessment of the method’s efficacy.

Conclusion

  • Under the optimized conditions, the new method is valid for the identification and resolution of the medetomidine enantiomers in various matrices used for drug testing and analysis.
  • This modified method allows for more straightforward and routine analysis, which was previously a challenge with protein-based chiral columns.

Cite This Article

APA
Karakka Kal AK, Nalakath J, Kunhamu Karatt T, Perwad Z, Mathew B, Subhahar M. (2020). Development and validation of a chiral LC-MS method for the enantiomeric resolution of (+) and (-)-medetomidine in equine plasma by using polysaccharide-based chiral stationary phases. Chirality, 32(3), 314-323. https://doi.org/10.1002/chir.23166

Publication

Chirality
ISSN: 1520-636X
NlmUniqueID: 8914261
Country: United States
Language: English
Volume: 32
Issue: 3
Pages: 314-323

Researcher Affiliations

Karakka Kal, Abdul Khader
  • Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, United Arab Emirates.
Nalakath, Jahfar
  • Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, United Arab Emirates.
Kunhamu Karatt, Tajudheen
  • Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, United Arab Emirates.
Perwad, Zubair
  • Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, United Arab Emirates.
Mathew, Binoy
  • Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, United Arab Emirates.
Subhahar, Michael
  • Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, United Arab Emirates.

MeSH Terms

  • Animals
  • Cellulose / chemistry
  • Chromatography, Liquid / methods
  • Dexmedetomidine / blood
  • Dexmedetomidine / isolation & purification
  • Horses
  • Limit of Detection
  • Medetomidine / blood
  • Medetomidine / chemistry
  • Medetomidine / isolation & purification
  • Spectrometry, Mass, Electrospray Ionization / methods
  • Stereoisomerism

References

This article includes 42 references
  1. Konstandi M, Sotiropoulos I, Matsubara T. Adrenoceptor-stimulated inflammatory response in stress-induced serum amyloid A synthesis.. Psychopharmacology (Berl) 2019;236(6):1687-1699.
    doi: 10.1007/s00213-018-5149-4google scholar: lookup
  2. Hedenqvist P, Roughvan JV, Flecknel PA. Sufentanil and medetomidine anesthesia in the rat and its reversal with atipamezole and butorphanol.. Lab Anim 2000;34(3):244-251.
  3. Bylund DB, Regan JW, Faber JE, Hieble JP, Triggle CR, Ruffolo RR. Vascular alpha-adrenoceptors: from the gene to the human.. Can J Physiol Pharmacol 1995;73(5):533-543.
  4. Timmermans PB, van Zwieten PA. Vasoconstriction mediated by postsynaptic alpha 2-adrenoceptor stimulation.. Naunyn Schmiedebergs Arch Pharmacol 1980;313(1):17-20.
  5. Vaha-Vahe T. The clinical efficacy of medetomidine.. Acta Vet Scand Suppl 1989;85:151-154.
  6. Vainio O. Introduction to the clinical pharmacology of medetomidine.. Acta Vet Scand Suppl 1989;85:85-88.
  7. Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine.. Clin Pharmacokinet 2017;56(8):893-913.
  8. Scheinin M, Kallio A, Koulu M, Viikari J, Schinin H. Sedative and cardiovascular effects of medetomidine, a novel selective α2-adrenoceptor agonist, in healthy volunteers.. Br J Clin Pharmacol 1987;24(4):443-451.
  9. Roughan JV, Ojeda OB, Flecknell PA. The influence of pre-anaesthetic administration of buprenorphine on the anaesthetic effects of ketamine/medetomidine and pentobarbitone in rats and the consequences of repeated anaesthesia.. Lab Anim 1999;33:234-242.
  10. Virtanen R. Pharmacological profiles of medetomidine and its antagonist atipamezole.. Acta Vet Scand Suppl 1989;85:29-37.
  11. Jones CR. Perioperative uses of dexmedetomidine.. Int Anesthesiol Clin 2013;51(2):81-96.
  12. Cormack JR, Orme RM, Costello TG. The role of α2-agonists in neurosurgery.. J Clin Neurosci 2005;12(4):375-378.
  13. Vaha-Vahe AT. The clinical effectiveness of atipamezole as a medetomidine antagonist in the dog.. J Vet Pharmacol Ther 1990;13:189-205.
  14. Larsen RS, Loomis MR, Kelly BT, Sladky KK, Stoskopf MK, Horne WA. Cardio respiratory effects of medetomidine-butorphanol, medetomidine-butorphanol-diazepam, and medetomidine-butorphanol-ketamine in captive red wolves (Canis rufus).. J Zoo Wildl Med 2002;33(2):101-107.
  15. Haskins SC, Patz JD, Farver TB. Xylazine and xylazine-ketamine in dogs.. J Am Vet Med Assoc 1986;47:636-641.
  16. Salonen JS. Pharmacokinetics of medetomidine.. Acta Vet Scand Suppl 1989;85:49-54.
  17. Salonen JS, Eloranta M. Biotransformation of medetomidine in the rat.. Xenobiotica 1990;20(5):471-480.
  18. Hui YH, Marsh KC, Menacherry S. Analytical method development for the simultaneous quantitation of dexmedetomidine and three potential metabolites in plasma.. J Chromatogr A 1997;762(1-2):281-291.
  19. Salonen JS. Tissue-specificity of hydroxylation and N-methylation of arylalkyl-imidazoles.. Pharmacol Toxicol 1991;69(1):1-4.
  20. Islam MR, Mahdi JG, Bowen ID. Pharmacological importance of stereo-chemical resolution of enantiomeric drugs.. Drug Saf 1997;17(3):149-165.
  21. European Community. Council Directive 96/22/EC concerning the prohibition on the use in stock farming of certain substances having a hormonal or thyrostatic action and of ß-agonists.. European Communities Official Journal 1996;125:3-9.
  22. Davis E, Loiacono R, Summers RJ. The rush to adrenaline: drugs in sport acting on the β-adrenergic system.. Br J Pharmacol 2009;154:584-597.
  23. . The World Anti-Doping Code. International Standard, the Prohibited List 2015.. .
  24. Savola JM, Virtanen R. Central α2-adrenoceptors are highly stereo-selective for dexmedetomidine, the dextro enantiomer of medetomidine.. Eur J Pharmacol 1991;195(2):193-199.
  25. Vickery RG, Sheridan BC, Segal IS, Maze M. Anesthetic and hemodynamic effects of the stereo-isomers of medetomidine, an alpha 2-adrenergic agonist, in halothane-anesthetized dogs.. Anesth Anal 1988;67(7):611-615.
  26. Choobdari E, Fakhraian H, Hassan PM. Anion effect on the binary and ternary phase diagrams of chiral medetomidine salts and conglomerate crystal formation.. Chirality 2014;26(3):183-188.
    doi: 10.1002/chir.22299google scholar: lookup
  27. Sara MP, Marcela AP. Enantiomeric resolution of albuterol sulfate by preferential crystallization.. Tetrahedron: Asymmetry 2007;18:1170-1175.
  28. Diaz-Muñoz G, Miranda IL, Sartori SK, de Rezende DC, Alves Nogueira Diaz MA. Use of chiral auxiliaries in the asymmetric synthesis of biologically active compounds: A review.. Chirality 2019;1-37.
    doi: 10.1002/chir.23103google scholar: lookup
  29. Tadashi S, Motoki K, Mitsuhiro W, Hidemasa N, Masanori O, Hidemoto K. Optical resolution by preferential crystallization of (RS)-2-amino-3-(2-carboxyethylthio) propanoic acid.. Biosci Biotechnol Biochem 1998;62:818-820.
    doi: 10.1271/bbb.62.818google scholar: lookup
  30. Abdul KKK, Tajudheen KK, Ramy S, Moses P, Meissir S, Jahfar N. Separation of ephedrine and pseudoephedrine enantiomers using a polysaccharide-based chiral column: a normal phase liquid chromatography-high-resolution mass spectrometry approach.. Chirality 2019;1-7.
    doi: 10.1002/chir.23104google scholar: lookup
  31. Yiwen Z, Shun Y, Hao Z, Hang S. Chiral separation of pharmaceuticals by high performance liquid chromatography.. Current Pharmaceutical Analysis 2018;6:114-130.
  32. Abdul KKK, Tajudheen KK, Moses P, Samir M, Jahfar N. Separation and determination of the enantiomeric levamisole and dexamisole in equine plasma samples using chiral polysaccharide column/LC-MS/MS.. Current Analytical Chemistry 2019;15:1-17.
    doi: 10.2174/1573411015666190808103143google scholar: lookup
  33. Tajudheen KK, Jahfar N, Zubair P, et al. J Mass Spectrom. 2018;53:1046-1058.
  34. Maier NM, Franco P, Lindner W. Separation of enantiomers: needs, challenges, perspectives.. J Chromatogr A 2001;906:3-33.
  35. Tajudheen KK, Abdul KKK, Ramy S, Jahfar N, Zubair P. Use of polysaccharide-based chiral columns: enantiomeric separation of seven pairs of abused drugs by high-performance liquid chromatography-mass spectrometry.. Forensic Toxicology 2019;37:254-260.
  36. Liming P, Swapna J, Chankvetadzeb B, Farkasa T. Reversed-phase chiral HPLC and LC/MS analysis with tris (chloromethylphenylcarbamate) derivatives of cellulose and amylose as chiral stationary phases.. J Chromatogr A 2010;1217:6942-6955.
  37. Abdul K, Sajith AM, Syed AP, Nagaswarupa HP, Muralidharan A. New J Chem. 2014;38:1294-1305.
  38. Li S, Liu B, Xue M, Yu J, Guo X. Enantioseparation and determination of flumequine enantiomers in multiple food matrices with chiral liquid chromatography coupled with tandem mass spectrometry.. Chirality 2019;1-11.
    doi: 10.1002/chir.23125google scholar: lookup
  39. Tajudheen KK, Ramy S, Jahfar N, Zubair P, Peter HA, Abdul KKK. Separation and identification of the epimeric doping agents-dexamethasone and betamethasone in equine urine and plasma: A reversed phase chiral chromatographic approach.. Steroids 2018;140:77-82.
  40. Krait S, Scriba GK. Quality by design-assisted development of a capillary electrophoresis method for the chiral purity determination of dexmedetomidine.. Electrophoresis 2018;39(20):2575-2580.
    doi: 10.1002/elps.201800100google scholar: lookup
  41. Orn G, Lahtonen K, Jalonen H. Direct high-performance liquid chromatographic separation of (+)- and (-)-medetomidine hydrochloride with an α1-acid glycoprotein chiral column.. J Chromatogr 1990;506:627-635.
  42. Shah VP, Midha KK, Dighe S. Analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies.. J Pharm Sci 1992;9:309-331.

Citations

This article has been cited 1 times.
  1. Bui CV, Rosenau T, Hettegger H. Polysaccharide- and β-Cyclodextrin-Based Chiral Selectors for Enantiomer Resolution: Recent Developments and Applications.. Molecules 2021 Jul 16;26(14).
    doi: 10.3390/molecules26144322pubmed: 34299597google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.